SLC2A1 and neoplasm: With ongoing progression of the disease, tumor cells of mCRPC tend to change the expression profile of proteins on the cell surface, commonly including an upregulation of glucose transporter 1 (GLUT1) to meet the tumor cells higher demand for glucose, which results from an intensified energy metabolism by glycolysis (22).